The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksODX.L Share News (ODX)

  • There is currently no data for ODX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: Omega Covid test gets CE mark; Creo revenue up

Thu, 03rd Feb 2022 11:00

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

----------

AIM - WINNERS

----------

Omega Diagnostics Group PLC, up 24% at 11.76 pence, 12-month range 6.50p-117.98p. The Alva, Scotland-based medical diagnostics company successfully attains a CE mark for its Visitect Covid-19 antigen test. "The company remains in discussions with commercial partners about how best to service the European market and other territories that recognise the CE mark. Omega's commercial offering will be via B2B partners and distributors, and not through a direct-to-consumer strategy," Omega adds.

----------

Creo Medical Group PLC, up 16% at 137.00 pence, 12-month range 116.50p-236.00p. The medical device company, with a focus on surgical endoscopy expects revenue for 2021 to top expectations at "just over" GBP25 million from GBP9.4 million in 2020.

----------

AIM - LOSERS

----------

Actual Experience PLC, down 15% at 12.90p, 12-month range 12.00p-135.00p. The Bath-based analytics-as-a-service company says its annual loss widens to GBP5.9 million in 2021 from GBP5.0 million in 2020. Revenue declines 11% to GBP1.7 million from GBP2.0 million. "Our sales team are engaged, directly or with partners, in multiple sales opportunities. Our clear focus in the coming months is to convert these opportunities to recurring 'continuous improvement' revenue streams," the company explains. Actual Experience accepts that shareholders have been "frustrated" with progress to date. "However, one of these lessons is that sales cycles will typically be longer than initially expected and therefore our planning has been adjusted to accommodate this timing," the company adds. Shares hit their 12-month low on Thursday.

----------

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
9 Jun 2020 11:14

UK TRADING UPDATE SUMMARY: Omega Wins First Order For Antibody Test

UK TRADING UPDATE SUMMARY: Omega Wins First Order For Antibody Test

Read more
9 Jun 2020 10:45

Omega Diagnostics halts development of allergy products

(Sharecast News) - Medical diagnostics company Omega Diagnostics said on Tuesday that it would take a hit of £8.73m after halting development of its allergy products.

Read more
3 Jun 2020 10:28

Omega Diagnostics sees 'significant progress' in Covid-19 antibody test

(Sharecast News) - Medical diagnostics company Omega said on Wednesday that the UK Rapid Test Consortium has made "significant progress" in developing a Covid-19 lateral flow antibody test that can be used by people in their homes.

Read more
28 Apr 2020 17:09

Omega Diagnostics Inks Supply Pact For HIV Testing Kit

Omega Diagnostics Inks Supply Pact For HIV Testing Kit

Read more
27 Apr 2020 13:51

UK TRADING UPDATE SUMMARY: Novacyt Called Upon To Ramp Up UK Testing

UK TRADING UPDATE SUMMARY: Novacyt Called Upon To Ramp Up UK Testing

Read more
20 Apr 2020 12:54

UK TRADING UPDATE SUMMARY: Omega Diagnostics Signs Antibody Test Deal

UK TRADING UPDATE SUMMARY: Omega Diagnostics Signs Antibody Test Deal

Read more
20 Apr 2020 09:35

Omega Diagnostics inks deal with Mologic over Covid-19 antibody test

(Sharecast News) - Medical diagnostics company Omega Diagnostics has signed a material transfer agreement with Mologic, it announced on Monday, to formalise a partnership to provide manufacturing capability for Mologic's Covid-19 first generation 'ELISA' diagnostics test.

Read more
2 Apr 2020 16:02

UK TRADING UPDATE SUMMARY: M&C Saatchi Feels Virus Pain

UK TRADING UPDATE SUMMARY: M&C Saatchi Feels Virus Pain

Read more
17 Jan 2020 11:11

Omega Diagnostics Gets Approval For VISITECT CD4 350 Test In Nigeria

Omega Diagnostics Gets Approval For VISITECT CD4 350 Test In Nigeria

Read more
17 Jan 2020 07:47

Omega Diagnostics geta approval for HIV test in Nigeria

(Sharecast News) - Medical diagnostics company Omega Diagnostics has received approval from the Federal Ministry of Health in Nigeria, to enable its 'VISITECT CD4 350' test product to be deployed in that country, it announced on Friday.

Read more
2 Dec 2019 13:14

Omega Diagnostics swings to statutory loss as it focuses on continuing operations

(Sharecast News) - Medical diagnostics company Omega Diagnostics reported a 6% improvement in revenue from continuing operations in its first half on Monday, to £4.46m.

Read more
2 Dec 2019 10:39

Omega Diagnostics Swings To Interim Loss, Wins Another VISITECT Order

Omega Diagnostics Swings To Interim Loss, Wins Another VISITECT Order

Read more
22 Oct 2019 13:34

Omega Diagnostics Predicts 7% Rise In Interim Revenue

Omega Diagnostics Predicts 7% Rise In Interim Revenue

Read more
22 Oct 2019 12:29

Omega Diagnostics sees continuing revenue improve in first half

(Sharecast News) - Allergy, food intolerance and infectious disease-focussed medical diagnostics company Omega Diagnostics updated the market on its trading for the six months ended 30 September on Tuesday, reporting that turnover was expected to be £4.46m, representing a 5% increase over the prior period from continuing operations.

Read more
23 Sep 2019 11:01

Omega Diagnostics Swings To Annual Profit, Plans GBP1.7 Million Raise

(Alliance News) - Omega Diagnostics Group PLC said Monday it swung to a profit following the divestment of several businesses, even as this led to a decline in revenue.Also, the medical it

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.